

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of hematopoietic progenitor cell differentiation (GO:1901534) | 6.29195586 |
| 2 | DNA deamination (GO:0045006) | 5.17224822 |
| 3 | behavioral response to nicotine (GO:0035095) | 4.92069196 |
| 4 | ribosomal small subunit assembly (GO:0000028) | 4.48201433 |
| 5 | maturation of SSU-rRNA (GO:0030490) | 4.10049346 |
| 6 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.02106841 |
| 7 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 4.00313472 |
| 8 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 4.00313472 |
| 9 | regulation of translation, ncRNA-mediated (GO:0045974) | 4.00313472 |
| 10 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.92456081 |
| 11 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.89363173 |
| 12 | telomere maintenance via recombination (GO:0000722) | 3.83738959 |
| 13 | protein-cofactor linkage (GO:0018065) | 3.82281598 |
| 14 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.79635652 |
| 15 | cellular response to ATP (GO:0071318) | 3.74410158 |
| 16 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.71543112 |
| 17 | DNA replication checkpoint (GO:0000076) | 3.62862146 |
| 18 | positive regulation of defense response to virus by host (GO:0002230) | 3.58443532 |
| 19 | L-fucose catabolic process (GO:0042355) | 3.52487028 |
| 20 | fucose catabolic process (GO:0019317) | 3.52487028 |
| 21 | L-fucose metabolic process (GO:0042354) | 3.52487028 |
| 22 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.49368844 |
| 23 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.49284495 |
| 24 | mitotic recombination (GO:0006312) | 3.46749694 |
| 25 | DNA strand elongation (GO:0022616) | 3.38335629 |
| 26 | pseudouridine synthesis (GO:0001522) | 3.37888305 |
| 27 | interferon-gamma production (GO:0032609) | 3.29412579 |
| 28 | attachment of spindle microtubules to kinetochore (GO:0008608) | 3.26831627 |
| 29 | positive regulation of megakaryocyte differentiation (GO:0045654) | 3.26678563 |
| 30 | tRNA methylation (GO:0030488) | 3.23966844 |
| 31 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.23618880 |
| 32 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.22746070 |
| 33 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.22746070 |
| 34 | NADH dehydrogenase complex assembly (GO:0010257) | 3.22746070 |
| 35 | rRNA methylation (GO:0031167) | 3.22334305 |
| 36 | activated T cell proliferation (GO:0050798) | 3.21757899 |
| 37 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.20318510 |
| 38 | viral transcription (GO:0019083) | 3.18080067 |
| 39 | definitive hemopoiesis (GO:0060216) | 3.17634201 |
| 40 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.17476563 |
| 41 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.12596594 |
| 42 | kinetochore assembly (GO:0051382) | 3.11636104 |
| 43 | protein complex biogenesis (GO:0070271) | 3.11535749 |
| 44 | translational termination (GO:0006415) | 3.11130809 |
| 45 | folic acid metabolic process (GO:0046655) | 3.10968642 |
| 46 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.10583856 |
| 47 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.10377557 |
| 48 | detection of light stimulus involved in visual perception (GO:0050908) | 3.10377557 |
| 49 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.07675879 |
| 50 | ribosomal small subunit biogenesis (GO:0042274) | 3.05710705 |
| 51 | proteasome assembly (GO:0043248) | 3.04781297 |
| 52 | cellular anion homeostasis (GO:0030002) | 3.04592480 |
| 53 | telomere maintenance via telomere lengthening (GO:0010833) | 3.00855913 |
| 54 | rRNA modification (GO:0000154) | 2.98653795 |
| 55 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.98555040 |
| 56 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.95223711 |
| 57 | axoneme assembly (GO:0035082) | 2.95168344 |
| 58 | regulation of natural killer cell differentiation (GO:0032823) | 2.93929570 |
| 59 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.93053454 |
| 60 | termination of RNA polymerase III transcription (GO:0006386) | 2.90556169 |
| 61 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.90556169 |
| 62 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.90318134 |
| 63 | DNA replication initiation (GO:0006270) | 2.90224562 |
| 64 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.89921743 |
| 65 | DNA synthesis involved in DNA repair (GO:0000731) | 2.89485255 |
| 66 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.89048524 |
| 67 | CENP-A containing nucleosome assembly (GO:0034080) | 2.88828904 |
| 68 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.88256939 |
| 69 | respiratory chain complex IV assembly (GO:0008535) | 2.87475065 |
| 70 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.86529233 |
| 71 | regulation of RIG-I signaling pathway (GO:0039535) | 2.86527698 |
| 72 | replication fork processing (GO:0031297) | 2.85998605 |
| 73 | sulfation (GO:0051923) | 2.85756147 |
| 74 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.84986326 |
| 75 | kinetochore organization (GO:0051383) | 2.84750097 |
| 76 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.83509058 |
| 77 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.83097317 |
| 78 | cotranslational protein targeting to membrane (GO:0006613) | 2.82273431 |
| 79 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.82093133 |
| 80 | regulation of gene silencing by miRNA (GO:0060964) | 2.82093133 |
| 81 | regulation of gene silencing by RNA (GO:0060966) | 2.82093133 |
| 82 | mitotic metaphase plate congression (GO:0007080) | 2.81015263 |
| 83 | methionine metabolic process (GO:0006555) | 2.80992015 |
| 84 | regulation of memory T cell differentiation (GO:0043380) | 2.79865061 |
| 85 | protein targeting to ER (GO:0045047) | 2.78597192 |
| 86 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.78491166 |
| 87 | translational elongation (GO:0006414) | 2.78000404 |
| 88 | response to pheromone (GO:0019236) | 2.77738452 |
| 89 | mRNA transcription from RNA polymerase II promoter (GO:0042789) | 2.77720262 |
| 90 | cellular response to dsRNA (GO:0071359) | 2.77195195 |
| 91 | rRNA catabolic process (GO:0016075) | 2.75075870 |
| 92 | indole-containing compound catabolic process (GO:0042436) | 2.74119358 |
| 93 | indolalkylamine catabolic process (GO:0046218) | 2.74119358 |
| 94 | tryptophan catabolic process (GO:0006569) | 2.74119358 |
| 95 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.72154585 |
| 96 | ATP synthesis coupled proton transport (GO:0015986) | 2.72154585 |
| 97 | negative regulation of telomere maintenance (GO:0032205) | 2.71601050 |
| 98 | recombinational repair (GO:0000725) | 2.71510086 |
| 99 | N-terminal protein amino acid acetylation (GO:0006474) | 2.70813630 |
| 100 | cytochrome complex assembly (GO:0017004) | 2.70732094 |
| 101 | double-strand break repair via homologous recombination (GO:0000724) | 2.69589541 |
| 102 | chromatin remodeling at centromere (GO:0031055) | 2.69516143 |
| 103 | protein localization to endoplasmic reticulum (GO:0070972) | 2.68164956 |
| 104 | DNA replication-independent nucleosome organization (GO:0034724) | 2.66444362 |
| 105 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.66444362 |
| 106 | methionine biosynthetic process (GO:0009086) | 2.65885050 |
| 107 | negative regulation of mast cell activation (GO:0033004) | 2.64796932 |
| 108 | ribosomal large subunit biogenesis (GO:0042273) | 2.63599930 |
| 109 | cellular response to interleukin-15 (GO:0071350) | 2.63068452 |
| 110 | S-adenosylmethionine metabolic process (GO:0046500) | 2.62038929 |
| 111 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.62031108 |
| 112 | indolalkylamine metabolic process (GO:0006586) | 2.61992117 |
| 113 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.61496372 |
| 114 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.60870821 |
| 115 | regulation of hexokinase activity (GO:1903299) | 2.60782167 |
| 116 | regulation of glucokinase activity (GO:0033131) | 2.60782167 |
| 117 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.60507184 |
| 118 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.59357152 |
| 119 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.59172415 |
| 120 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.59172415 |
| 121 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.58585364 |
| 122 | regulation of mesoderm development (GO:2000380) | 2.58347309 |
| 123 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.58011031 |
| 124 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.57436755 |
| 125 | positive regulation of B cell differentiation (GO:0045579) | 2.57330141 |
| 126 | pteridine-containing compound metabolic process (GO:0042558) | 2.56652191 |
| 127 | negative regulation of T cell differentiation in thymus (GO:0033085) | 2.56515441 |
| 128 | L-methionine salvage (GO:0071267) | 2.56208207 |
| 129 | L-methionine biosynthetic process (GO:0071265) | 2.56208207 |
| 130 | amino acid salvage (GO:0043102) | 2.56208207 |
| 131 | one-carbon metabolic process (GO:0006730) | 2.55859015 |
| 132 | histone mRNA metabolic process (GO:0008334) | 2.55715893 |
| 133 | tRNA modification (GO:0006400) | 2.55395626 |
| 134 | adaptation of signaling pathway (GO:0023058) | 2.54887607 |
| 135 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.54820932 |
| 136 | iron-sulfur cluster assembly (GO:0016226) | 2.53719765 |
| 137 | metallo-sulfur cluster assembly (GO:0031163) | 2.53719765 |
| 138 | tetrahydrofolate metabolic process (GO:0046653) | 2.53635266 |
| 139 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.53279472 |
| 140 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.52484553 |
| 141 | chaperone-mediated protein transport (GO:0072321) | 2.51152793 |
| 142 | tRNA processing (GO:0008033) | 2.51084047 |
| 143 | cellular ketone body metabolic process (GO:0046950) | 2.50255320 |
| 144 | cardiovascular system development (GO:0072358) | 2.49801815 |
| 145 | telomere maintenance (GO:0000723) | 2.48867748 |
| 146 | telomere organization (GO:0032200) | 2.48366670 |
| 147 | cellular response to exogenous dsRNA (GO:0071360) | 2.48291787 |
| 148 | protein K11-linked deubiquitination (GO:0035871) | 2.48003849 |
| 149 | regulation of mitochondrial translation (GO:0070129) | 2.47924556 |
| 150 | RNA methylation (GO:0001510) | 2.47851039 |
| 151 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.45792597 |
| 152 | regulation of defense response to virus by host (GO:0050691) | 2.45063529 |
| 153 | fat-soluble vitamin catabolic process (GO:0042363) | 2.44954804 |
| 154 | vitamin catabolic process (GO:0009111) | 2.44954804 |
| 155 | mitotic cell cycle arrest (GO:0071850) | 2.44761473 |
| 156 | regulation of sister chromatid cohesion (GO:0007063) | 2.44303234 |
| 157 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.44220460 |
| 158 | mast cell degranulation (GO:0043303) | 2.44095495 |
| 159 | mast cell activation involved in immune response (GO:0002279) | 2.44095495 |
| 160 | sulfur amino acid biosynthetic process (GO:0000097) | 2.43953061 |
| 161 | GDP-mannose metabolic process (GO:0019673) | 2.43916470 |
| 162 | RNA destabilization (GO:0050779) | 2.43301147 |
| 163 | neuronal action potential (GO:0019228) | 2.42663284 |
| 164 | establishment of protein localization to Golgi (GO:0072600) | 2.42411961 |
| 165 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 2.42363629 |
| 166 | reciprocal meiotic recombination (GO:0007131) | 2.42152915 |
| 167 | reciprocal DNA recombination (GO:0035825) | 2.42152915 |
| 168 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.40847808 |
| 169 | folic acid-containing compound metabolic process (GO:0006760) | 2.40738073 |
| 170 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.39962630 |
| 171 | intracellular protein transmembrane import (GO:0044743) | 2.39502144 |
| 172 | synaptic transmission, cholinergic (GO:0007271) | 2.39207828 |
| 173 | metaphase plate congression (GO:0051310) | 2.39159038 |
| 174 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.38483435 |
| 175 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.38168046 |
| 176 | positive regulation of antigen processing and presentation (GO:0002579) | 2.37795631 |
| 177 | cytidine deamination (GO:0009972) | 2.36580132 |
| 178 | cytidine metabolic process (GO:0046087) | 2.36580132 |
| 179 | cytidine catabolic process (GO:0006216) | 2.36580132 |
| 180 | immunoglobulin mediated immune response (GO:0016064) | 2.36485281 |
| 181 | heme biosynthetic process (GO:0006783) | 2.36341368 |
| 182 | tolerance induction (GO:0002507) | 2.35592849 |
| 183 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.35183599 |
| 184 | RNA modification (GO:0009451) | 2.34480513 |
| 185 | signal peptide processing (GO:0006465) | 2.34270202 |
| 186 | negative regulation of T cell mediated immunity (GO:0002710) | 2.33887031 |
| 187 | mast cell activation (GO:0045576) | 2.32268505 |
| 188 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.32132342 |
| 189 | piRNA metabolic process (GO:0034587) | 2.32010610 |
| 190 | centriole replication (GO:0007099) | 2.31927023 |
| 191 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.31730998 |
| 192 | viral life cycle (GO:0019058) | 2.31611522 |
| 193 | kynurenine metabolic process (GO:0070189) | 2.31562830 |
| 194 | mitotic nuclear envelope disassembly (GO:0007077) | 2.31556611 |
| 195 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.31383468 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.31371336 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.00544152 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.42825479 |
| 4 | VDR_22108803_ChIP-Seq_LS180_Human | 3.30367829 |
| 5 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.19259235 |
| 6 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.07598558 |
| 7 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.01744393 |
| 8 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.88758438 |
| 9 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.86834566 |
| 10 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.73359986 |
| 11 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.57411431 |
| 12 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.56648675 |
| 13 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.53588362 |
| 14 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.52575550 |
| 15 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.48280678 |
| 16 | EWS_26573619_Chip-Seq_HEK293_Human | 2.48272042 |
| 17 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.47735809 |
| 18 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.47430560 |
| 19 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.42216698 |
| 20 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.36867574 |
| 21 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.32350256 |
| 22 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.31324450 |
| 23 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.31004241 |
| 24 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.26420179 |
| 25 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.21080975 |
| 26 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.20556957 |
| 27 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.18459785 |
| 28 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.13828516 |
| 29 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.13167510 |
| 30 | FUS_26573619_Chip-Seq_HEK293_Human | 2.12563425 |
| 31 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.10704773 |
| 32 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.09583580 |
| 33 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.09249458 |
| 34 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.05323006 |
| 35 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.05101283 |
| 36 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.04634017 |
| 37 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.04291251 |
| 38 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.02917560 |
| 39 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.98560526 |
| 40 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.96977871 |
| 41 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.94183138 |
| 42 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.92393539 |
| 43 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.91729678 |
| 44 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.88716411 |
| 45 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.87840997 |
| 46 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.87589034 |
| 47 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.85978929 |
| 48 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.84872535 |
| 49 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.84769366 |
| 50 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.84466514 |
| 51 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.83468137 |
| 52 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.81638254 |
| 53 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.81219941 |
| 54 | * E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.79702508 |
| 55 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.78518022 |
| 56 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.77337525 |
| 57 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.74466010 |
| 58 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.74310853 |
| 59 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.72845423 |
| 60 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.71899069 |
| 61 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.71278218 |
| 62 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.69559524 |
| 63 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.69510239 |
| 64 | GATA1_22025678_ChIP-Seq_K562_Human | 1.69122034 |
| 65 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.68389433 |
| 66 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.66814173 |
| 67 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.64515847 |
| 68 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.63999229 |
| 69 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.62489538 |
| 70 | MYC_22102868_ChIP-Seq_BL_Human | 1.61618169 |
| 71 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.60976273 |
| 72 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.56679099 |
| 73 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.53612294 |
| 74 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.48536725 |
| 75 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.48479227 |
| 76 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.48260911 |
| 77 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.47683510 |
| 78 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.46614691 |
| 79 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.46480231 |
| 80 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.46082389 |
| 81 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.45989037 |
| 82 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.45696056 |
| 83 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.45655269 |
| 84 | P300_19829295_ChIP-Seq_ESCs_Human | 1.44382677 |
| 85 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42320427 |
| 86 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.41204235 |
| 87 | GATA3_26560356_Chip-Seq_TH2_Human | 1.40920096 |
| 88 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.40623971 |
| 89 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.40421115 |
| 90 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.39489076 |
| 91 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.39238526 |
| 92 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.38454924 |
| 93 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.38177343 |
| 94 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.37203266 |
| 95 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.37203266 |
| 96 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.33835348 |
| 97 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.32671422 |
| 98 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.32367626 |
| 99 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29316529 |
| 100 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.29019539 |
| 101 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.27212369 |
| 102 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.26715450 |
| 103 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.26662299 |
| 104 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.24656574 |
| 105 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.24360043 |
| 106 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.24360043 |
| 107 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.24295663 |
| 108 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.22822154 |
| 109 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.22310983 |
| 110 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.22080894 |
| 111 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.21233553 |
| 112 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.20913076 |
| 113 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.18608716 |
| 114 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.18285853 |
| 115 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.18272339 |
| 116 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.18109173 |
| 117 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.17196620 |
| 118 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.16564721 |
| 119 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.16029099 |
| 120 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.16029099 |
| 121 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.15747283 |
| 122 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.15747283 |
| 123 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.15597437 |
| 124 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.15175259 |
| 125 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.15055562 |
| 126 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.15005903 |
| 127 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.14326654 |
| 128 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.14097307 |
| 129 | NCOR_22424771_ChIP-Seq_293T_Human | 1.12651931 |
| 130 | AR_20517297_ChIP-Seq_VCAP_Human | 1.10554534 |
| 131 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10441102 |
| 132 | AR_25329375_ChIP-Seq_VCAP_Human | 1.10282899 |
| 133 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.10161356 |
| 134 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.09831111 |
| 135 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.08795015 |
| 136 | STAT3_23295773_ChIP-Seq_U87_Human | 1.08739450 |
| 137 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.07578537 |
| 138 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.06783929 |
| 139 | * MYB_26560356_Chip-Seq_TH1_Human | 1.06637725 |
| 140 | MYB_26560356_Chip-Seq_TH2_Human | 1.06273990 |
| 141 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.05710386 |
| 142 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.05059780 |
| 143 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.04740104 |
| 144 | ERA_21632823_ChIP-Seq_H3396_Human | 1.04493652 |
| 145 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.03904449 |
| 146 | UTX_26944678_Chip-Seq_JUKART_Human | 1.03454952 |
| 147 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.02833771 |
| 148 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.02580829 |
| 149 | TCF4_23295773_ChIP-Seq_U87_Human | 1.02523805 |
| 150 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.02437031 |
| 151 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.02302841 |
| 152 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.01800230 |
| 153 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.01363735 |
| 154 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.01266130 |
| 155 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.00667239 |
| 156 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.00494390 |
| 157 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.98895536 |
| 158 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.98735730 |
| 159 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.98505396 |
| 160 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.98366937 |
| 161 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.98231109 |
| 162 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.97933800 |
| 163 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.97884809 |
| 164 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97647860 |
| 165 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.97559126 |
| 166 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.97307753 |
| 167 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.97100588 |
| 168 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.96763026 |
| 169 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.96082745 |
| 170 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.96041207 |
| 171 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.95874847 |
| 172 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.95406724 |
| 173 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.94004787 |
| 174 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.93529865 |
| 175 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.92253807 |
| 176 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.89702078 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001986_abnormal_taste_sensitivity | 4.00730738 |
| 2 | MP0003693_abnormal_embryo_hatching | 3.79844759 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 3.48861179 |
| 4 | MP0008877_abnormal_DNA_methylation | 3.11712048 |
| 5 | MP0008007_abnormal_cellular_replicative | 2.95367339 |
| 6 | MP0001968_abnormal_touch/_nociception | 2.78997191 |
| 7 | MP0003195_calcinosis | 2.71145449 |
| 8 | MP0003950_abnormal_plasma_membrane | 2.66124834 |
| 9 | MP0002139_abnormal_hepatobiliary_system | 2.49070932 |
| 10 | MP0003111_abnormal_nucleus_morphology | 2.45146976 |
| 11 | MP0003077_abnormal_cell_cycle | 2.42759693 |
| 12 | MP0001835_abnormal_antigen_presentation | 2.41741655 |
| 13 | MP0010094_abnormal_chromosome_stability | 2.41716106 |
| 14 | MP0003656_abnormal_erythrocyte_physiolo | 2.37073002 |
| 15 | MP0002396_abnormal_hematopoietic_system | 2.32867703 |
| 16 | MP0005360_urolithiasis | 2.27917347 |
| 17 | MP0005671_abnormal_response_to | 2.27223143 |
| 18 | MP0005174_abnormal_tail_pigmentation | 2.25553376 |
| 19 | MP0002132_abnormal_respiratory_system | 2.10648671 |
| 20 | MP0003436_decreased_susceptibility_to | 2.07932215 |
| 21 | MP0003718_maternal_effect | 2.06502340 |
| 22 | MP0002736_abnormal_nociception_after | 2.06245942 |
| 23 | MP0009785_altered_susceptibility_to | 2.02986128 |
| 24 | MP0000569_abnormal_digit_pigmentation | 2.01883960 |
| 25 | MP0004957_abnormal_blastocyst_morpholog | 1.94405780 |
| 26 | MP0002876_abnormal_thyroid_physiology | 1.93074669 |
| 27 | MP0005551_abnormal_eye_electrophysiolog | 1.91943637 |
| 28 | MP0003763_abnormal_thymus_physiology | 1.91528043 |
| 29 | MP0009333_abnormal_splenocyte_physiolog | 1.90086412 |
| 30 | MP0008058_abnormal_DNA_repair | 1.89996891 |
| 31 | MP0004043_abnormal_pH_regulation | 1.88364201 |
| 32 | MP0005025_abnormal_response_to | 1.87211959 |
| 33 | MP0008872_abnormal_physiological_respon | 1.86256047 |
| 34 | MP0003646_muscle_fatigue | 1.85906867 |
| 35 | MP0005365_abnormal_bile_salt | 1.83219809 |
| 36 | MP0004147_increased_porphyrin_level | 1.82975834 |
| 37 | MP0005085_abnormal_gallbladder_physiolo | 1.76519038 |
| 38 | MP0003787_abnormal_imprinting | 1.76490654 |
| 39 | MP0001800_abnormal_humoral_immune | 1.75548272 |
| 40 | MP0002398_abnormal_bone_marrow | 1.74422794 |
| 41 | MP0006072_abnormal_retinal_apoptosis | 1.72772482 |
| 42 | MP0003186_abnormal_redox_activity | 1.72430737 |
| 43 | MP0004142_abnormal_muscle_tone | 1.71124674 |
| 44 | MP0004885_abnormal_endolymph | 1.70234145 |
| 45 | MP0005389_reproductive_system_phenotype | 1.69712379 |
| 46 | MP0002723_abnormal_immune_serum | 1.68772032 |
| 47 | MP0009840_abnormal_foam_cell | 1.68441937 |
| 48 | MP0002419_abnormal_innate_immunity | 1.67219112 |
| 49 | MP0005000_abnormal_immune_tolerance | 1.65544028 |
| 50 | MP0002452_abnormal_antigen_presenting | 1.62784798 |
| 51 | MP0006292_abnormal_olfactory_placode | 1.61023069 |
| 52 | MP0002420_abnormal_adaptive_immunity | 1.59944098 |
| 53 | MP0000490_abnormal_crypts_of | 1.58208091 |
| 54 | MP0003724_increased_susceptibility_to | 1.57717322 |
| 55 | MP0002837_dystrophic_cardiac_calcinosis | 1.57599987 |
| 56 | MP0001819_abnormal_immune_cell | 1.57180078 |
| 57 | MP0000685_abnormal_immune_system | 1.57011537 |
| 58 | MP0002160_abnormal_reproductive_system | 1.53579686 |
| 59 | MP0008995_early_reproductive_senescence | 1.51735743 |
| 60 | MP0000689_abnormal_spleen_morphology | 1.51548093 |
| 61 | MP0005423_abnormal_somatic_nervous | 1.48413793 |
| 62 | MP0000716_abnormal_immune_system | 1.48202758 |
| 63 | MP0001919_abnormal_reproductive_system | 1.47235632 |
| 64 | MP0002429_abnormal_blood_cell | 1.46141247 |
| 65 | MP0003011_delayed_dark_adaptation | 1.46023596 |
| 66 | MP0005464_abnormal_platelet_physiology | 1.45050640 |
| 67 | MP0008057_abnormal_DNA_replication | 1.42972338 |
| 68 | MP0008875_abnormal_xenobiotic_pharmacok | 1.42943484 |
| 69 | MP0002138_abnormal_hepatobiliary_system | 1.40923571 |
| 70 | MP0009745_abnormal_behavioral_response | 1.37787177 |
| 71 | MP0002405_respiratory_system_inflammati | 1.37445514 |
| 72 | MP0002722_abnormal_immune_system | 1.37074526 |
| 73 | MP0005058_abnormal_lysosome_morphology | 1.36846741 |
| 74 | MP0002166_altered_tumor_susceptibility | 1.36547644 |
| 75 | MP0005253_abnormal_eye_physiology | 1.35064205 |
| 76 | MP0002148_abnormal_hypersensitivity_rea | 1.34838607 |
| 77 | MP0002928_abnormal_bile_duct | 1.34694845 |
| 78 | MP0001790_abnormal_immune_system | 1.33989780 |
| 79 | MP0005387_immune_system_phenotype | 1.33989780 |
| 80 | MP0001502_abnormal_circadian_rhythm | 1.32283762 |
| 81 | MP0002102_abnormal_ear_morphology | 1.31918907 |
| 82 | MP0000427_abnormal_hair_cycle | 1.31412007 |
| 83 | MP0008469_abnormal_protein_level | 1.30812621 |
| 84 | MP0000465_gastrointestinal_hemorrhage | 1.29424146 |
| 85 | MP0001853_heart_inflammation | 1.28557198 |
| 86 | MP0002272_abnormal_nervous_system | 1.28419716 |
| 87 | MP0005075_abnormal_melanosome_morpholog | 1.25719981 |
| 88 | MP0009046_muscle_twitch | 1.25434670 |
| 89 | MP0004133_heterotaxia | 1.23013614 |
| 90 | MP0006036_abnormal_mitochondrial_physio | 1.22998708 |
| 91 | MP0003786_premature_aging | 1.18525371 |
| 92 | MP0001501_abnormal_sleep_pattern | 1.17302234 |
| 93 | MP0002006_tumorigenesis | 1.17208109 |
| 94 | MP0002019_abnormal_tumor_incidence | 1.16014859 |
| 95 | MP0001486_abnormal_startle_reflex | 1.14830421 |
| 96 | MP0000631_abnormal_neuroendocrine_gland | 1.14808401 |
| 97 | MP0000703_abnormal_thymus_morphology | 1.14035251 |
| 98 | MP0005083_abnormal_biliary_tract | 1.13948930 |
| 99 | MP0002095_abnormal_skin_pigmentation | 1.13800680 |
| 100 | MP0001873_stomach_inflammation | 1.13364202 |
| 101 | MP0004130_abnormal_muscle_cell | 1.12381783 |
| 102 | MP0003191_abnormal_cellular_cholesterol | 1.10273025 |
| 103 | MP0008961_abnormal_basal_metabolism | 1.10043201 |
| 104 | MP0004808_abnormal_hematopoietic_stem | 1.09195146 |
| 105 | MP0005646_abnormal_pituitary_gland | 1.07071139 |
| 106 | MP0003136_yellow_coat_color | 1.03549257 |
| 107 | MP0005645_abnormal_hypothalamus_physiol | 1.03177171 |
| 108 | MP0002234_abnormal_pharynx_morphology | 1.03141281 |
| 109 | MP0009697_abnormal_copulation | 1.02590986 |
| 110 | MP0009379_abnormal_foot_pigmentation | 1.02291670 |
| 111 | MP0009763_increased_sensitivity_to | 1.01572217 |
| 112 | MP0000015_abnormal_ear_pigmentation | 1.01454097 |
| 113 | MP0001845_abnormal_inflammatory_respons | 1.00644187 |
| 114 | MP0004145_abnormal_muscle_electrophysio | 1.00185818 |
| 115 | MP0001764_abnormal_homeostasis | 0.99294637 |
| 116 | MP0000313_abnormal_cell_death | 0.97314174 |
| 117 | MP0000609_abnormal_liver_physiology | 0.96611987 |
| 118 | MP0005310_abnormal_salivary_gland | 0.96575567 |
| 119 | MP0003943_abnormal_hepatobiliary_system | 0.94769913 |
| 120 | MP0002163_abnormal_gland_morphology | 0.94288148 |
| 121 | MP0005332_abnormal_amino_acid | 0.93531704 |
| 122 | MP0010329_abnormal_lipoprotein_level | 0.92536833 |
| 123 | MP0002277_abnormal_respiratory_mucosa | 0.92046814 |
| 124 | MP0004381_abnormal_hair_follicle | 0.91077000 |
| 125 | MP0001188_hyperpigmentation | 0.90872812 |
| 126 | MP0001119_abnormal_female_reproductive | 0.89408358 |
| 127 | MP0002638_abnormal_pupillary_reflex | 0.87383404 |
| 128 | MP0002735_abnormal_chemical_nociception | 0.87158999 |
| 129 | MP0005636_abnormal_mineral_homeostasis | 0.86804536 |
| 130 | MP0005084_abnormal_gallbladder_morpholo | 0.86425023 |
| 131 | MP0008260_abnormal_autophagy | 0.86056161 |
| 132 | MP0010386_abnormal_urinary_bladder | 0.86050956 |
| 133 | MP0003866_abnormal_defecation | 0.84505675 |
| 134 | MP0010155_abnormal_intestine_physiology | 0.84183946 |
| 135 | MP0002693_abnormal_pancreas_physiology | 0.83875925 |
| 136 | MP0000598_abnormal_liver_morphology | 0.83691404 |
| 137 | MP0001765_abnormal_ion_homeostasis | 0.82144703 |
| 138 | MP0001545_abnormal_hematopoietic_system | 0.81062929 |
| 139 | MP0005397_hematopoietic_system_phenotyp | 0.81062929 |
| 140 | MP0004019_abnormal_vitamin_homeostasis | 0.80634175 |
| 141 | MP0004215_abnormal_myocardial_fiber | 0.80624649 |
| 142 | MP0004742_abnormal_vestibular_system | 0.80165714 |
| 143 | MP0001440_abnormal_grooming_behavior | 0.78973942 |
| 144 | MP0002064_seizures | 0.78142944 |
| 145 | MP0004924_abnormal_behavior | 0.77653845 |
| 146 | MP0005386_behavior/neurological_phenoty | 0.77653845 |
| 147 | MP0001970_abnormal_pain_threshold | 0.77156281 |
| 148 | MP0003252_abnormal_bile_duct | 0.77039160 |
| 149 | MP0001756_abnormal_urination | 0.77038087 |
| 150 | MP0003878_abnormal_ear_physiology | 0.77007162 |
| 151 | MP0005377_hearing/vestibular/ear_phenot | 0.77007162 |
| 152 | MP0001905_abnormal_dopamine_level | 0.76920016 |
| 153 | MP0001324_abnormal_eye_pigmentation | 0.75907275 |
| 154 | MP0005451_abnormal_body_composition | 0.75831577 |
| 155 | MP0000858_altered_metastatic_potential | 0.73103615 |
| 156 | MP0005319_abnormal_enzyme/_coenzyme | 0.73049802 |
| 157 | MP0003699_abnormal_female_reproductive | 0.71804627 |
| 158 | MP0000350_abnormal_cell_proliferation | 0.71716608 |
| 159 | MP0009764_decreased_sensitivity_to | 0.71588165 |
| 160 | MP0002572_abnormal_emotion/affect_behav | 0.70593677 |
| 161 | MP0002067_abnormal_sensory_capabilities | 0.70489151 |
| 162 | MP0000470_abnormal_stomach_morphology | 0.70298420 |
| 163 | MP0001666_abnormal_nutrient_absorption | 0.70221523 |
| 164 | MP0009643_abnormal_urine_homeostasis | 0.69379108 |
| 165 | MP0003183_abnormal_peptide_metabolism | 0.69110255 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Aplastic anemia (HP:0001915) | 4.81435629 |
| 2 | Chronic hepatic failure (HP:0100626) | 4.46254020 |
| 3 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.92993693 |
| 4 | Reduced antithrombin III activity (HP:0001976) | 3.85578797 |
| 5 | Congenital stationary night blindness (HP:0007642) | 3.81689413 |
| 6 | Birth length less than 3rd percentile (HP:0003561) | 3.72029091 |
| 7 | Reticulocytopenia (HP:0001896) | 3.66555428 |
| 8 | Pancreatic cysts (HP:0001737) | 3.63043719 |
| 9 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.40999774 |
| 10 | Microretrognathia (HP:0000308) | 3.35045786 |
| 11 | Attenuation of retinal blood vessels (HP:0007843) | 3.32123680 |
| 12 | Abnormal number of erythroid precursors (HP:0012131) | 3.28462390 |
| 13 | Nephronophthisis (HP:0000090) | 3.28415616 |
| 14 | Pallor (HP:0000980) | 3.18981571 |
| 15 | Recurrent fungal infections (HP:0002841) | 3.18084725 |
| 16 | Recurrent viral infections (HP:0004429) | 3.17602543 |
| 17 | Type I transferrin isoform profile (HP:0003642) | 3.07814349 |
| 18 | Pancreatic fibrosis (HP:0100732) | 3.07701048 |
| 19 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.05723424 |
| 20 | Abnormality of midbrain morphology (HP:0002418) | 3.05043419 |
| 21 | Molar tooth sign on MRI (HP:0002419) | 3.05043419 |
| 22 | True hermaphroditism (HP:0010459) | 2.90197625 |
| 23 | Albinism (HP:0001022) | 2.86031221 |
| 24 | Abnormality of the renal cortex (HP:0011035) | 2.80137100 |
| 25 | Abnormality of the renal medulla (HP:0100957) | 2.78698336 |
| 26 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.78315347 |
| 27 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.77118976 |
| 28 | Recurrent bacterial skin infections (HP:0005406) | 2.73674282 |
| 29 | Chronic sinusitis (HP:0011109) | 2.73355286 |
| 30 | Intrahepatic cholestasis (HP:0001406) | 2.69854497 |
| 31 | Petechiae (HP:0000967) | 2.69579921 |
| 32 | Genetic anticipation (HP:0003743) | 2.68414875 |
| 33 | Recurrent abscess formation (HP:0002722) | 2.66297011 |
| 34 | Thrombocytosis (HP:0001894) | 2.65515086 |
| 35 | Autoimmune thrombocytopenia (HP:0001973) | 2.58152607 |
| 36 | Prolonged partial thromboplastin time (HP:0003645) | 2.57522204 |
| 37 | Breast hypoplasia (HP:0003187) | 2.55900710 |
| 38 | Pancytopenia (HP:0001876) | 2.55408009 |
| 39 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.49465480 |
| 40 | Neutropenia (HP:0001875) | 2.48742744 |
| 41 | Lipid accumulation in hepatocytes (HP:0006561) | 2.46770446 |
| 42 | Congenital, generalized hypertrichosis (HP:0004540) | 2.46594443 |
| 43 | Eczematoid dermatitis (HP:0000976) | 2.44971822 |
| 44 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.43686732 |
| 45 | Methylmalonic acidemia (HP:0002912) | 2.42062809 |
| 46 | Panhypogammaglobulinemia (HP:0003139) | 2.40525528 |
| 47 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.40441910 |
| 48 | Oral leukoplakia (HP:0002745) | 2.39648572 |
| 49 | Macrocytic anemia (HP:0001972) | 2.39574676 |
| 50 | Stomach cancer (HP:0012126) | 2.39237886 |
| 51 | Acute myeloid leukemia (HP:0004808) | 2.38133713 |
| 52 | Abnormality of T cell physiology (HP:0011840) | 2.36459510 |
| 53 | Recurrent cutaneous fungal infections (HP:0011370) | 2.35904639 |
| 54 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.35904639 |
| 55 | Hypoplasia of the pons (HP:0012110) | 2.35169867 |
| 56 | Increased hepatocellular lipid droplets (HP:0006565) | 2.34336004 |
| 57 | Recurrent skin infections (HP:0001581) | 2.33809172 |
| 58 | Stomatitis (HP:0010280) | 2.33638121 |
| 59 | Abnormality of the pons (HP:0007361) | 2.33172053 |
| 60 | Rough bone trabeculation (HP:0100670) | 2.32977044 |
| 61 | IgG deficiency (HP:0004315) | 2.31835086 |
| 62 | Abnormal drinking behavior (HP:0030082) | 2.30884754 |
| 63 | Polydipsia (HP:0001959) | 2.30884754 |
| 64 | Tubular atrophy (HP:0000092) | 2.30426157 |
| 65 | Abnormal protein glycosylation (HP:0012346) | 2.27230211 |
| 66 | Abnormal glycosylation (HP:0012345) | 2.27230211 |
| 67 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.27230211 |
| 68 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.27230211 |
| 69 | Rib fusion (HP:0000902) | 2.26946009 |
| 70 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.25692391 |
| 71 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.24724283 |
| 72 | Abnormality of alanine metabolism (HP:0010916) | 2.24724283 |
| 73 | Hyperalaninemia (HP:0003348) | 2.24724283 |
| 74 | Abnormality of renal resorption (HP:0011038) | 2.21987558 |
| 75 | IgM deficiency (HP:0002850) | 2.21806842 |
| 76 | Bone marrow hypocellularity (HP:0005528) | 2.21446798 |
| 77 | Hypoplasia of the thymus (HP:0000778) | 2.20904274 |
| 78 | Mitochondrial inheritance (HP:0001427) | 2.19549013 |
| 79 | Renal cortical cysts (HP:0000803) | 2.19262227 |
| 80 | Hyperventilation (HP:0002883) | 2.18553912 |
| 81 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.18253484 |
| 82 | Chronic otitis media (HP:0000389) | 2.17756319 |
| 83 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.17052677 |
| 84 | Premature graying of hair (HP:0002216) | 2.16093939 |
| 85 | Recurrent bronchitis (HP:0002837) | 2.15521762 |
| 86 | Hypobetalipoproteinemia (HP:0003563) | 2.14516277 |
| 87 | Protruding tongue (HP:0010808) | 2.14116985 |
| 88 | Patellar aplasia (HP:0006443) | 2.14103864 |
| 89 | Chromsome breakage (HP:0040012) | 2.12939722 |
| 90 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.12229244 |
| 91 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.12229244 |
| 92 | Prolonged bleeding time (HP:0003010) | 2.11784772 |
| 93 | Progressive cerebellar ataxia (HP:0002073) | 2.11521149 |
| 94 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.11124916 |
| 95 | Medial flaring of the eyebrow (HP:0010747) | 2.10475863 |
| 96 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.08826477 |
| 97 | Decreased central vision (HP:0007663) | 2.07427991 |
| 98 | Severe combined immunodeficiency (HP:0004430) | 2.06035898 |
| 99 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.05911564 |
| 100 | Acute lymphatic leukemia (HP:0006721) | 2.05905106 |
| 101 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.05900591 |
| 102 | Abnormality of the renal collecting system (HP:0004742) | 2.05590224 |
| 103 | Optic neuritis (HP:0100653) | 2.04820740 |
| 104 | Retrobulbar optic neuritis (HP:0100654) | 2.04820740 |
| 105 | Increased CSF lactate (HP:0002490) | 2.04617353 |
| 106 | Clumsiness (HP:0002312) | 2.04205760 |
| 107 | Combined immunodeficiency (HP:0005387) | 2.04195419 |
| 108 | Abnormality of eosinophils (HP:0001879) | 2.03794814 |
| 109 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.03269386 |
| 110 | Lymphopenia (HP:0001888) | 2.02915383 |
| 111 | Absent thumb (HP:0009777) | 2.02818747 |
| 112 | Pendular nystagmus (HP:0012043) | 2.02030743 |
| 113 | Abnormality of DNA repair (HP:0003254) | 2.01889507 |
| 114 | Abnormality of T cells (HP:0002843) | 2.00781204 |
| 115 | Volvulus (HP:0002580) | 1.99982725 |
| 116 | Microcytic anemia (HP:0001935) | 1.98948751 |
| 117 | Cellular immunodeficiency (HP:0005374) | 1.98944422 |
| 118 | Gaze-evoked nystagmus (HP:0000640) | 1.98302094 |
| 119 | Abnormality of serum amino acid levels (HP:0003112) | 1.97511373 |
| 120 | Duplicated collecting system (HP:0000081) | 1.97487391 |
| 121 | Myelodysplasia (HP:0002863) | 1.97072445 |
| 122 | Methylmalonic aciduria (HP:0012120) | 1.96559987 |
| 123 | Abolished electroretinogram (ERG) (HP:0000550) | 1.96333719 |
| 124 | Megaloblastic anemia (HP:0001889) | 1.96302651 |
| 125 | Cystic liver disease (HP:0006706) | 1.95939976 |
| 126 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.95391559 |
| 127 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.95391559 |
| 128 | Pustule (HP:0200039) | 1.94886266 |
| 129 | Joint hemorrhage (HP:0005261) | 1.94642081 |
| 130 | Spastic paraparesis (HP:0002313) | 1.94408788 |
| 131 | Broad-based gait (HP:0002136) | 1.93657013 |
| 132 | Cellulitis (HP:0100658) | 1.93486280 |
| 133 | Abnormality of T cell number (HP:0011839) | 1.92980822 |
| 134 | Hyperbilirubinemia (HP:0002904) | 1.92171592 |
| 135 | Abnormal albumin level (HP:0012116) | 1.92076972 |
| 136 | Hypoalbuminemia (HP:0003073) | 1.92076972 |
| 137 | Hypochromic anemia (HP:0001931) | 1.91981608 |
| 138 | Poikiloderma (HP:0001029) | 1.91242952 |
| 139 | Type II lissencephaly (HP:0007260) | 1.90528236 |
| 140 | Abnormal trabecular bone morphology (HP:0100671) | 1.90216587 |
| 141 | Acute necrotizing encephalopathy (HP:0006965) | 1.90122831 |
| 142 | Amniotic constriction ring (HP:0009775) | 1.89758650 |
| 143 | Abnormality of placental membranes (HP:0011409) | 1.89758650 |
| 144 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.89476242 |
| 145 | Exertional dyspnea (HP:0002875) | 1.88333007 |
| 146 | Large for gestational age (HP:0001520) | 1.87804172 |
| 147 | Leukocytosis (HP:0001974) | 1.87677491 |
| 148 | Thyroiditis (HP:0100646) | 1.86860934 |
| 149 | Hyperglycinemia (HP:0002154) | 1.86844450 |
| 150 | Prolonged neonatal jaundice (HP:0006579) | 1.84772188 |
| 151 | Obstructive lung disease (HP:0006536) | 1.84373824 |
| 152 | Chronic obstructive pulmonary disease (HP:0006510) | 1.84373824 |
| 153 | Meningitis (HP:0001287) | 1.84250629 |
| 154 | Male pseudohermaphroditism (HP:0000037) | 1.83854075 |
| 155 | Granulocytopenia (HP:0001913) | 1.81915419 |
| 156 | Constricted visual fields (HP:0001133) | 1.81541999 |
| 157 | T lymphocytopenia (HP:0005403) | 1.80341228 |
| 158 | Mediastinal lymphadenopathy (HP:0100721) | 1.80202836 |
| 159 | Hypoproteinemia (HP:0003075) | 1.80123339 |
| 160 | Encephalitis (HP:0002383) | 1.79964055 |
| 161 | Conjugated hyperbilirubinemia (HP:0002908) | 1.79876438 |
| 162 | Lymphoma (HP:0002665) | 1.79809150 |
| 163 | Decreased circulating renin level (HP:0003351) | 1.79583495 |
| 164 | Renal Fanconi syndrome (HP:0001994) | 1.78869536 |
| 165 | Increased intramyocellular lipid droplets (HP:0012240) | 1.78782022 |
| 166 | 3-Methylglutaconic aciduria (HP:0003535) | 1.78553869 |
| 167 | Small hand (HP:0200055) | 1.78231859 |
| 168 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.78101144 |
| 169 | Muscle fiber atrophy (HP:0100295) | 1.77795911 |
| 170 | Polyuria (HP:0000103) | 1.77782236 |
| 171 | Abnormality of methionine metabolism (HP:0010901) | 1.77490161 |
| 172 | Eosinophilia (HP:0001880) | 1.77261939 |
| 173 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.75901679 |
| 174 | Ectopic kidney (HP:0000086) | 1.75011307 |
| 175 | Asplenia (HP:0001746) | 1.73117687 |
| 176 | Hepatocellular necrosis (HP:0001404) | 1.72968084 |
| 177 | Progressive macrocephaly (HP:0004481) | 1.71095976 |
| 178 | Chorioretinal atrophy (HP:0000533) | 1.70647763 |
| 179 | Abnormality of homocysteine metabolism (HP:0010919) | 1.69897434 |
| 180 | Homocystinuria (HP:0002156) | 1.69897434 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK16 | 4.99646458 |
| 2 | FRK | 4.84860049 |
| 3 | TIE1 | 4.26882215 |
| 4 | IRAK4 | 3.86115502 |
| 5 | BUB1 | 3.66105208 |
| 6 | TEC | 2.78871689 |
| 7 | ADRBK2 | 2.76227045 |
| 8 | MAP4K1 | 2.62917546 |
| 9 | MAPK15 | 2.34558455 |
| 10 | ACVR1B | 2.31509790 |
| 11 | WEE1 | 2.15182184 |
| 12 | NME2 | 2.14054414 |
| 13 | TXK | 2.07083798 |
| 14 | WNK4 | 2.04932770 |
| 15 | BMPR1B | 2.03728970 |
| 16 | KIT | 1.96221735 |
| 17 | TESK2 | 1.90777502 |
| 18 | VRK1 | 1.88940530 |
| 19 | BCKDK | 1.84321677 |
| 20 | NEK2 | 1.81752210 |
| 21 | BLK | 1.75447886 |
| 22 | WNK3 | 1.74960218 |
| 23 | INSRR | 1.73612256 |
| 24 | RPS6KA4 | 1.72110265 |
| 25 | EIF2AK1 | 1.71196015 |
| 26 | ZAP70 | 1.66082296 |
| 27 | KDR | 1.62850378 |
| 28 | MAP4K2 | 1.56437099 |
| 29 | IRAK3 | 1.53560138 |
| 30 | IKBKE | 1.51140457 |
| 31 | BTK | 1.49673125 |
| 32 | CASK | 1.47598108 |
| 33 | TAOK3 | 1.44766926 |
| 34 | TLK1 | 1.44221103 |
| 35 | OXSR1 | 1.39198299 |
| 36 | MAP2K6 | 1.35439701 |
| 37 | MAP3K6 | 1.34426498 |
| 38 | MAP3K14 | 1.33186420 |
| 39 | TYK2 | 1.32791161 |
| 40 | MAPK13 | 1.32664621 |
| 41 | PIK3CA | 1.31035990 |
| 42 | BRSK2 | 1.26508497 |
| 43 | CAMKK2 | 1.23317853 |
| 44 | MUSK | 1.20489149 |
| 45 | SRPK1 | 1.20188134 |
| 46 | DYRK3 | 1.17783576 |
| 47 | NLK | 1.13906564 |
| 48 | CDC7 | 1.10933556 |
| 49 | JAK3 | 1.09415741 |
| 50 | TBK1 | 1.09200983 |
| 51 | NME1 | 1.08294970 |
| 52 | ADRBK1 | 1.07443595 |
| 53 | PLK4 | 1.06428759 |
| 54 | AKT3 | 1.06418442 |
| 55 | TNK2 | 1.04503575 |
| 56 | MST4 | 1.02878350 |
| 57 | FLT3 | 1.01834155 |
| 58 | GRK6 | 1.00364081 |
| 59 | ERN1 | 1.00157227 |
| 60 | MAPKAPK3 | 0.98018354 |
| 61 | PIM2 | 0.97487539 |
| 62 | IRAK1 | 0.96168333 |
| 63 | STK39 | 0.95680239 |
| 64 | GRK1 | 0.95653196 |
| 65 | ATR | 0.94548360 |
| 66 | LYN | 0.94236241 |
| 67 | EIF2AK2 | 0.92294087 |
| 68 | SYK | 0.90856480 |
| 69 | PLK1 | 0.88998399 |
| 70 | PRKCQ | 0.88605260 |
| 71 | DAPK2 | 0.88399391 |
| 72 | SGK2 | 0.88123222 |
| 73 | MAPK11 | 0.87445783 |
| 74 | STK10 | 0.87150134 |
| 75 | SIK2 | 0.84226932 |
| 76 | TTK | 0.83311760 |
| 77 | TRPM7 | 0.83182044 |
| 78 | PIM1 | 0.83029906 |
| 79 | AURKB | 0.81967460 |
| 80 | STK4 | 0.81576916 |
| 81 | BMPR2 | 0.81571805 |
| 82 | PHKG2 | 0.81138467 |
| 83 | PHKG1 | 0.81138467 |
| 84 | CSF1R | 0.78939239 |
| 85 | MKNK2 | 0.78290808 |
| 86 | CDK4 | 0.77585683 |
| 87 | STK11 | 0.76175888 |
| 88 | PBK | 0.75839401 |
| 89 | CDK7 | 0.72969273 |
| 90 | MKNK1 | 0.72920749 |
| 91 | TSSK6 | 0.69760338 |
| 92 | PAK3 | 0.66909118 |
| 93 | LCK | 0.66195137 |
| 94 | MAP3K10 | 0.65757300 |
| 95 | MARK3 | 0.65172161 |
| 96 | PRKCG | 0.65115954 |
| 97 | MAP3K11 | 0.64149113 |
| 98 | MAP3K4 | 0.61668975 |
| 99 | CHUK | 0.61430116 |
| 100 | MAP2K3 | 0.60458695 |
| 101 | MAP2K2 | 0.60384332 |
| 102 | EPHA3 | 0.60039886 |
| 103 | CHEK2 | 0.59869175 |
| 104 | SGK494 | 0.58704531 |
| 105 | SGK223 | 0.58704531 |
| 106 | RPS6KB2 | 0.57683748 |
| 107 | BRSK1 | 0.57461716 |
| 108 | SGK1 | 0.55574870 |
| 109 | NUAK1 | 0.55183646 |
| 110 | IKBKB | 0.54445212 |
| 111 | PASK | 0.54062048 |
| 112 | HCK | 0.52914387 |
| 113 | ZAK | 0.52808946 |
| 114 | PRKCE | 0.52038952 |
| 115 | RPS6KA6 | 0.51760986 |
| 116 | CSK | 0.51499842 |
| 117 | RPS6KA5 | 0.51167122 |
| 118 | MAP2K4 | 0.50675430 |
| 119 | BRD4 | 0.48444146 |
| 120 | WNK1 | 0.47071634 |
| 121 | CSNK2A1 | 0.47030743 |
| 122 | ABL2 | 0.46618185 |
| 123 | GRK7 | 0.46493554 |
| 124 | CHEK1 | 0.45793192 |
| 125 | CDK9 | 0.44410983 |
| 126 | FGFR2 | 0.44273045 |
| 127 | CAMK1 | 0.41382164 |
| 128 | HIPK2 | 0.40983495 |
| 129 | EEF2K | 0.40322855 |
| 130 | PRKACA | 0.39702771 |
| 131 | JAK1 | 0.39316801 |
| 132 | PIK3CG | 0.39011167 |
| 133 | TGFBR1 | 0.38648188 |
| 134 | PRKG1 | 0.37995079 |
| 135 | DYRK2 | 0.37289681 |
| 136 | LATS1 | 0.36864224 |
| 137 | FGFR4 | 0.36614056 |
| 138 | MAPK7 | 0.36513326 |
| 139 | PINK1 | 0.36500299 |
| 140 | OBSCN | 0.35981269 |
| 141 | LRRK2 | 0.35322192 |
| 142 | CDK19 | 0.34257044 |
| 143 | FES | 0.33786473 |
| 144 | AURKA | 0.33350582 |
| 145 | ATM | 0.33167543 |
| 146 | PRKCD | 0.33149781 |
| 147 | MAPKAPK5 | 0.32787437 |
| 148 | CSNK2A2 | 0.32423364 |
| 149 | MAP3K8 | 0.31860708 |
| 150 | TNIK | 0.30807828 |
| 151 | MAPK12 | 0.30667185 |
| 152 | CDK3 | 0.29608149 |
| 153 | AKT1 | 0.29396116 |
| 154 | ABL1 | 0.29332911 |
| 155 | PRKCH | 0.29201359 |
| 156 | ITK | 0.28587226 |
| 157 | RIPK1 | 0.28203796 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 3.94738789 |
| 2 | Mismatch repair_Homo sapiens_hsa03430 | 2.99240826 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 2.95972555 |
| 4 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.68087754 |
| 5 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.60892842 |
| 6 | Base excision repair_Homo sapiens_hsa03410 | 2.58259418 |
| 7 | RNA polymerase_Homo sapiens_hsa03020 | 2.52379427 |
| 8 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.40719958 |
| 9 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.34934059 |
| 10 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.24183370 |
| 11 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.19961535 |
| 12 | Homologous recombination_Homo sapiens_hsa03440 | 2.10109877 |
| 13 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.02351952 |
| 14 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.01976139 |
| 15 | Proteasome_Homo sapiens_hsa03050 | 1.95833502 |
| 16 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.94480064 |
| 17 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.92066499 |
| 18 | RNA degradation_Homo sapiens_hsa03018 | 1.83409368 |
| 19 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.82678307 |
| 20 | Spliceosome_Homo sapiens_hsa03040 | 1.80924640 |
| 21 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.80768164 |
| 22 | Phototransduction_Homo sapiens_hsa04744 | 1.76240739 |
| 23 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.72617683 |
| 24 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.71697919 |
| 25 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.69003815 |
| 26 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.64114145 |
| 27 | Parkinsons disease_Homo sapiens_hsa05012 | 1.63028792 |
| 28 | Histidine metabolism_Homo sapiens_hsa00340 | 1.62363012 |
| 29 | Nicotine addiction_Homo sapiens_hsa05033 | 1.61583578 |
| 30 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.60812376 |
| 31 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.58747624 |
| 32 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.56611450 |
| 33 | Protein export_Homo sapiens_hsa03060 | 1.51319427 |
| 34 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.48866378 |
| 35 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.48674223 |
| 36 | Asthma_Homo sapiens_hsa05310 | 1.48298444 |
| 37 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.47476434 |
| 38 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.45621581 |
| 39 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.43492595 |
| 40 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.42034164 |
| 41 | Cell cycle_Homo sapiens_hsa04110 | 1.39878316 |
| 42 | Basal transcription factors_Homo sapiens_hsa03022 | 1.38543085 |
| 43 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.36030538 |
| 44 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.36023786 |
| 45 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.34553128 |
| 46 | RNA transport_Homo sapiens_hsa03013 | 1.34435171 |
| 47 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.31692920 |
| 48 | Peroxisome_Homo sapiens_hsa04146 | 1.30970323 |
| 49 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.29951310 |
| 50 | Sulfur relay system_Homo sapiens_hsa04122 | 1.25003304 |
| 51 | Taste transduction_Homo sapiens_hsa04742 | 1.18949541 |
| 52 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.18768929 |
| 53 | Purine metabolism_Homo sapiens_hsa00230 | 1.17829699 |
| 54 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.17170666 |
| 55 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.15516045 |
| 56 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.14325725 |
| 57 | Huntingtons disease_Homo sapiens_hsa05016 | 1.14269824 |
| 58 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.12439017 |
| 59 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.09076572 |
| 60 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.08360821 |
| 61 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.07086986 |
| 62 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.07032626 |
| 63 | Alzheimers disease_Homo sapiens_hsa05010 | 1.06867883 |
| 64 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.04992821 |
| 65 | Circadian rhythm_Homo sapiens_hsa04710 | 1.03781289 |
| 66 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.01223178 |
| 67 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.94681128 |
| 68 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.94614590 |
| 69 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.92986510 |
| 70 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.90200400 |
| 71 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.89571158 |
| 72 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.89551347 |
| 73 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.88942429 |
| 74 | Measles_Homo sapiens_hsa05162 | 0.85714224 |
| 75 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.85255491 |
| 76 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.85084400 |
| 77 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.84338743 |
| 78 | Morphine addiction_Homo sapiens_hsa05032 | 0.84181056 |
| 79 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.81792507 |
| 80 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.81419182 |
| 81 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.78745403 |
| 82 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.78474775 |
| 83 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.78323687 |
| 84 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.76399868 |
| 85 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.74242691 |
| 86 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.74219619 |
| 87 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.74077103 |
| 88 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.72797570 |
| 89 | Legionellosis_Homo sapiens_hsa05134 | 0.72396537 |
| 90 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.72117727 |
| 91 | Retinol metabolism_Homo sapiens_hsa00830 | 0.72050787 |
| 92 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.71690557 |
| 93 | Olfactory transduction_Homo sapiens_hsa04740 | 0.70522072 |
| 94 | Leishmaniasis_Homo sapiens_hsa05140 | 0.68122135 |
| 95 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.67946787 |
| 96 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.67630190 |
| 97 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.67441546 |
| 98 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.65611493 |
| 99 | ABC transporters_Homo sapiens_hsa02010 | 0.64640397 |
| 100 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.62864190 |
| 101 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.62658353 |
| 102 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.62443597 |
| 103 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.59867575 |
| 104 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.59278632 |
| 105 | Circadian entrainment_Homo sapiens_hsa04713 | 0.58980830 |
| 106 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.58226947 |
| 107 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.58178653 |
| 108 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.58078431 |
| 109 | Metabolic pathways_Homo sapiens_hsa01100 | 0.56453961 |
| 110 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.56262391 |
| 111 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.55730263 |
| 112 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.54518566 |
| 113 | Lysine degradation_Homo sapiens_hsa00310 | 0.54444964 |
| 114 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.54074665 |
| 115 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.53699269 |
| 116 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.52286034 |
| 117 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.51174569 |
| 118 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.50805348 |
| 119 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.50537348 |
| 120 | Allograft rejection_Homo sapiens_hsa05330 | 0.49867751 |
| 121 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.48197376 |
| 122 | Other glycan degradation_Homo sapiens_hsa00511 | 0.48104609 |
| 123 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.46899860 |
| 124 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.46481466 |
| 125 | Influenza A_Homo sapiens_hsa05164 | 0.46091715 |
| 126 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.42724089 |
| 127 | Insulin secretion_Homo sapiens_hsa04911 | 0.41536464 |
| 128 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.39848184 |
| 129 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.39181139 |
| 130 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.38252151 |
| 131 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.37853851 |
| 132 | Mineral absorption_Homo sapiens_hsa04978 | 0.36878855 |
| 133 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.36342957 |
| 134 | Galactose metabolism_Homo sapiens_hsa00052 | 0.35892889 |
| 135 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.35747364 |
| 136 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.33094518 |
| 137 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.30824580 |
| 138 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.29863948 |
| 139 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.29542292 |
| 140 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.29001726 |
| 141 | Shigellosis_Homo sapiens_hsa05131 | 0.28588498 |
| 142 | Carbon metabolism_Homo sapiens_hsa01200 | 0.28144198 |
| 143 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.28102879 |
| 144 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.28068852 |
| 145 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.27968940 |
| 146 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.27880274 |

